Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score
Amanda Mocroft(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), P Francioli(University of Lusaka), Kai Zilmer(East Tallinn Central Hospital), Adriano Lazzarin(Vita-Salute San Raffaele University), Ole Kirk(University of Copenhagen), Bernard Hirschel(University of Geneva), Ladislav Machala, Bruno Ledergerber(University Hospital of Zurich), Peter Reiss(Amsterdam Institute for Global Health and Development), Jean-Paul Viard(Hôpital Necker-Enfants Malades), Andrew Phillips(Wake Forest University)
Cited by 54
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2008|1k